Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine for Prevention of Recurrent Persistent AF
NCT01349491Phase 3Terminated
- Sponsor
- University of Oklahoma
- Start
- Mar 2012
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ranolazine in Atrial fibrillation (AFib), sponsored by University of Oklahoma. Started Mar 2012; status: terminated.
02
Drugs
ranolazine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT01349491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01349491.